IRADIMED CORP — Director's Dealing 2021

Jun 30, 2021

SEC Form 4/A — Form 4/A

Issuer: IRADIMED CORP (IRMD)
CIK: 0001325618
Period of Report: 2020-12-07

Reporting Person: HAWKINS JAMES B (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-12-07	Common Stock	M	2185	—	Acquired	16000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-12-07	Restricted Stock Units	$	A	4074	Acquired		Common Stock (4074)	Direct
2020-12-07	Restricted Stock Units	$	M	2185	Disposed		Common Stock (2185)	Direct

Footnotes

F1: Restricted stock units convert to common stock on a one-for-one basis.

F2: Each restricted stock unit represents a contingent right to receive one share of Iradimed Corporation's common stock.

F3: This amendment is being filed to correct the amount of restricted stock units previously reported on the reporting person's Form 4 filed on December 9, 2020. The amount previously reported was 4,370 and it should have been 4,074.

F4: The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in two equal annual installments beginning on December 7, 2021. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.

F5: The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in two equal annual installments beginning on December 7, 2020. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.